23:58:49 EDT Mon 11 May 2026
Enter Symbol
or Name
USA
CA



Owlet Expands ANZ Product Suite with Launch of Dream Sight(TM) and Dream Duo(TM) 3, Bringing the World's Most Comprehensive Baby Monitoring System to More Families

2026-05-11 19:00 ET - News Release

Following a successful Dream Sock® launch, Owlet now offers its full award-winning monitoring ecosystem in ANZ — combining medically-certified health tracking with 2K HD video and the industry’s most advanced cybersecurity protections.


Company Website: https://owletcare.com
SYDNEY, Australia -- (Business Wire)

Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced the launch of Dream Sight and Dream Duo 3 across Australia and New Zealand. The expansion builds on the Company’s 2025 Dream Sock launch and brings Owlet’s full lineup of award-winning baby monitoring products to ANZ families for the first time.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511586578/en/

Named ‘Best for Monitoring Baby’s Health’ in the PARENTS 2026 Best for Baby Awards, Owlet Dream Duo 3 delivers a view of the baby’s wellness, sleep, and environment. Now available in ANZ.

Named ‘Best for Monitoring Baby’s Health’ in the PARENTS 2026 Best for Baby Awards, Owlet Dream Duo 3 delivers a view of the baby’s wellness, sleep, and environment. Now available in ANZ.

“When we launched Dream Sock in Australia and New Zealand late last year, the response from local families was extraordinary,” said Kurt Workman, Owlet’s President, Chief Executive Officer, and Co-Founder. “We are proud to give even more parents access to our smartest, most comprehensive monitors to date, and continue to build upon our vast set of infant sleep and health data.”

A Complete Monitoring Ecosystem, Now in ANZ

With this launch, Australian and New Zealand families can access Owlet’s full ecosystem of products:

  • Dream Sock: With clearance from Australia’s Therapeutic Goods Administration (TGA), and FDA clearance, the Company’s wearable smart baby monitor tracks pulse rate and oxygen level for infants 0–18 months, with real-time alerts sent directly to parents, and also provides sleep trends.
  • Dream Sight: An all-new, premium 2K HD video baby monitor with night vision, a 130-degree wide-angle lens, two-way talk, automatic video clip capture, motion, sound, and cry detection, and temperature and humidity monitoring. Protected by 256-bit encryption and industry-leading anti-hacking technology, Dream Sight is the only baby monitor awarded the SGS Cybersecurity Mark.
  • Dream Duo 3: Owlet’s most comprehensive baby monitoring system, combining Dream Sock and Dream Sight. Named ‘Best for Monitoring Baby’s Health’ in the PARENTS 2026 Best for Baby Awards, Dream Duo 3 delivers a view of the baby’s wellness, sleep, and environment.

All products integrate with the free Owlet Dream App (iOS and Android) for real-time health readings, smart alerts, and sleep trends. Families seeking deeper insights can subscribe to Owlet360™, which adds daily sleep reports, expanded trend analytics, extended video storage, comparative sleep data, and more.

Trusted by more than 2.5 million families around the globe, Owlet’s platform has generated a large and unique collection of pediatric health and sleep data. Parents who use Owlet monitors report meaningful outcomes: 96% of Owlet sock users have reported feeling less anxiety, and 94% have reported better quality of sleep.*

Dream Sight, Dream Duo 3, and Dream Sock are available now in Australia and New Zealand through Owlet’s local e-commerce website at www.owletcare.com.au and select retail partners.

*Based on a 2017 survey of 5,125 users of Owlet Smart Sock (Dangerfield et al., Global Pediatric Health, 2017). Results are self-reported and may not be representative of all users.

About Owlet, Inc.

Owlet, Inc. (NYSE: OWLT), a leading pediatric health platform, is the only company in the world to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors, delivering hospital-grade technology directly in the home. Our award-winning pediatric products and innovative software combine clinically tested monitoring systems, an integrated video platform, and a simple, easy-to-use app, providing parents with real-time health insights to stay informed on their child’s well-being, support restful sleep, and provide peace of mind anywhere. Since 2012, more than 2.5 million parents have trusted Owlet to monitor their children's well-being and sleep. This adoption has fueled one of the largest collections of pediatric health and sleep data in the world, powering innovations that bridge the critical gap between hospital and home. Owlet is driving a new standard in pediatric wellness by pairing advanced medical technology with consumer-friendly design. Our mission is simple yet ambitious: to give every baby and every family the best possible start in life. Learn more at www.owletcare.com and follow us on LinkedIn and Instagram for company news and updates.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the anticipated launch, availability, market acceptance, adoption, capabilities, and performance of the Company’s products and services in Australia and New Zealand, the expected benefits and features of such products and services, product enhancements, growth prospects, regulatory clearances, approvals, certifications and classifications, subscription offerings and related services, and the Company’s strategic initiatives, growth strategies and product development efforts. In some cases, you can identify forward-looking statements by terms such as “estimate,” “may,” “believes,” “plans,” “expects,” “anticipates,” “intends,” “goal,” “potential,” “continues,” “designed,” “seek,” “will,” the negation thereof, or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are based on the Company’s expectations at the time such statements are made, speak only as of the dates they are made, and are susceptible to a number of risks, uncertainties, and other factors. For all such forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. The Company’s actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by its forward-looking statements. Many important factors could affect the Company’s future results and cause those results to differ materially from those expressed in or implied by the Company’s forward-looking statements. Such factors include, but are not limited to: (i) the commercial success of Owlet’s products, including its subscription services, and the Company’s ability to support, scale and maintain its subscription services; (ii) the regulatory pathway for Owlet’s products, including submissions to, actions taken by and decisions and responses from regulators, such as the FDA, the TGA and other similar regulators outside of the United States, as well as Owlet’s ability to obtain and maintain regulatory approval or certification for its products and comply with ongoing regulatory requirements; (iii) Owlet’s competition and the Company’s ability to profitably grow and manage growth; (iv) the ability of Owlet to implement strategic initiatives, reduce costs, grow revenues, develop and launch new products, innovate and enhance existing products, meet customer demands and adapt to changes in consumer preferences and retail trends; (v) Owlet’s ability to acquire, defend and protect its intellectual property and satisfy regulatory requirements concerning privacy, data protection and cybersecurity, including for Owlet’s digital platforms and technologies; (vi) Owlet’s ability to maintain relationships with channel partners, customers, manufacturers and suppliers; (vii) impacts from compliance with applicable laws or regulations; (ix) the impact of and disruption to Owlet’s business, financial condition, operations, supply chain and logistics due to economic and other conditions beyond the Company’s control; (x) adverse impacts from other economic, business, regulatory, competitive or other factors, such as changes in discretionary consumer spending and consumer preferences; and (xi) other risks and uncertainties set forth in the Company’s other releases, public statements and filings with the U.S. Securities and Exchange Commission (“SEC”), including those identified in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and as any such factors may be updated from time to time in the Company’s other filings with the SEC. All such forward-looking statements attributable to the Company or any person acting on the Company’s behalf are expressly qualified in their entirety by the cautionary statements contained or referred to above. Moreover, the Company operates in an evolving environment. New risk factors and uncertainties may emerge from time to time, and factors that the Company currently deems immaterial may become material, and it is impossible for the Company to predict such events or how they may affect Owlet. Except as required by law, the Company assumes no obligation to update any forward-looking statements after the date of this press release, whether because of new information, future events or otherwise, although Owlet may do so from time to time. The Company does not endorse any projections regarding future performance that may be made by third parties.

Contacts:

Owlet Media Contacts:
pr@owletcare.com
owlet@hannahcranstonmedia.com

Owlet Investor Contact:
ir@owletcare.com

Source: Owlet, Inc.

© 2026 Canjex Publishing Ltd. All rights reserved.